Bridging traditional empirical formulations with modern bioequivalence and chemical manufacturing controls (CMC). Select an engineered program below to initiate project qualification.
In modern phytochemical manufacturing, therapeutic efficacy relies entirely on the precision of process validation. Enterprise buyers now require comprehensive evidence ensuring that active botanical substances remain pure, stable, and chemically consistent across scale-up cycles.
Global regulatory bodies such as the US FDA, EMA, and NMPA demand stringent chemical characterization. Simple extract ratios are obsolete. Sourcing partners demand chromatographic fingerprints, multi-constituent quantitative assays, and complete degradation kinetics.
Translating bench-scale extraction to pilot and metric-ton industrial campaigns frequently fails without rigorous pilot testing. Process studies pinpoint Critical Process Parameters (CPPs) to preserve active compound integrity while minimizing solvent and energy consumption.
Supply chain security requires continuous verification of pesticide residues, heavy metals, microbial limits, and polycyclic aromatic hydrocarbons (PAHs). Our protocols ensure full compliance with the European Pharmacopoeia (Ph. Eur.) and United States Pharmacopeia (USP).
Over 14 years of commercial and research engagements have created one of China's most robust botanical intelligence repositories, supporting international life-science leaders.
Addressing the complex technical bottlenecks across botanical discovery, chemical standardization, pre-clinical safety, and finished pharmaceutical formulation.
Botanical potency varies based on climatic conditions, soil composition, and harvest windows. Our phenotyping models map active yields across geographical origins and maturity levels to lock in optimal raw material specifications.
We eliminate undesirable impurities, pigments, and ballast compounds via macroporous resin fractionations, molecular distillation, and simulated moving bed (SMB) chromatography, delivering maximum purity without structural breakdown.
Actives often degrade due to oxidation, hygroscopicity, or thermal instability. Our formulation team designs microencapsulation, spray-drying, and liposomal delivery systems to guarantee shelf-life stability and targeted bioavailability.
Validating functional claims through GLP-compliant in vitro cellular models and in vivo animal systems. We generate actionable efficacy and safety data (LD50, acute, sub-chronic) to de-risk downstream clinical investments.
For brands and pharmaceutical partners developing dietary supplements or botanical drugs, we provide full protocol design, patient cohort tracking, and biostatistical analysis for regulatory filings.
Our pilot plants and cGMP partner facilities scale laboratory-proven formulations into finished commercial dosage formats: hard capsules, softgels, micro-tablets, functional oral liquids, and instantly dispersible granules.
Our engineering roadmap transitions conventional extraction into continuous, automated, data-driven manufacturing paradigms.
Integrating in-line NIR (Near-Infrared) spectrometry and automated refractive index sensors for real-time tracking of target compound concentrations during industrial solvent extractions.
Replacing toxic organic solvents with closed-loop Supercritical CO2 (scCO2) and subcritical water extraction techniques, maximizing yield for heat-sensitive phyto-constituents.
Deploying deep-learning models to predict solvent partition coefficients, optimize resin binding dynamics, and isolate active isomers from complex botanical matrices.
Shifting from traditional batch processing to continuous micro-reactor flows, eliminating batch variations, lowering energy overhead, and slashing cycle times by up to 60%.
International sourcing requires absolute IP confidentiality and transparent compliance. We maintain strict protocols to protect client interests across every engagement.
Projects operate under strict bilateral confidentiality agreements. Formulation structures, purification parameters, and clinical trial results remain our clients' exclusive IP. Internal firewalls ensure clean separation across all CDMO client campaigns.
Raw material assays and final product dossiers are aligned with regional regulatory requirements, including USP, Ph. Eur., British Pharmacopoeia (BP), and Chinese Pharmacopoeia (ChP), expediting drug and supplement registrations.
Our bilingual scientific project team provides full regulatory documentation support, including Certificates of Analysis (COAs), Technical Dossiers, stability study packages, and audit-ready batch records.
Comprehensive technical guidance for procurement executives, quality assurance directors, and formulation scientists.
Explore our core service pathways for full lifecycle contract research, validation, and commercial scale-up.
